Gemcitabine Plus Cisplatin in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer That Is Recurrent or Has Not Responded to Platinum-based Chemotherapy

State University of New York Health Science Center at Brooklyn, Brooklyn

Fox Chase Cancer Center, Philadelphia

Duke Comprehensive Cancer Center, Durham

Brookview Research, Inc., Nashville

Ireland Cancer Center, Cleveland

Cleveland Clinic Taussig Cancer Center, Cleveland

Ellis Fischel Cancer Center, Indianapolis

Ellis Fischel Cancer Center - Columbia, Columbia

University of Oklahoma College of Medicine, Oklahoma City

Community Hospital of Los Gatos, Los Gatos

H. Lee Moffitt Cancer Center and Research Institute, Tampa

Rush-Presbyterian-St. Luke's Medical Center, Chicago

University of Chicago Cancer Research Center, Chicago

Indiana University Cancer Center, Indianapolis

Holden Comprehensive Cancer Center, Iowa City

Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support, Bethesda

Tuft-New England Medical Center, Boston

University of Mississippi Medical Center, Jackson

Cooper Hospital/University Medical Center, Camden

Roswell Park Cancer Institute, Buffalo

State University of New York Health Sciences Center - Stony Brook, Stony Brook

Lineberger Comprehensive Cancer Center, UNC, Chapel Hill

Comprehensive Cancer Center at Wake Forest University, Winston-Salem

Abington Memorial Hospital, Abington

Milton S. Hershey Medical Center, Hershey

University of Pennsylvania Cancer Center, Philadelphia

Simmons Cancer Center - Dallas, Dallas

University of Texas Medical Branch, Galveston

CCOP - M.D. Anderson Research Base, Houston

University of Wisconsin Comprehensive Cancer Center, Madison

Norwegian Radium Hospital, Oslo